Dade Behring Introduces BCS(R) XP System: A Coagulation Analyzer for the High-Volume Laboratory.DEERFIELD, Ill. -- Customer-inspired features improve productivity, workflow and turn-around time for patient results Today at the American Association of Clinical Chemistry (AACC AACC American Association of Community Colleges (formerly American Association of Junior Colleges) AACC American Association for Clinical Chemistry AACC American Association of Cereal Chemists AACC Anne Arundel Community College ) Annual Meeting in Chicago, Illinois, Dade Behring Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :DADE) introduced the BCS (1) (The British Computer Society, Swindon, Wiltshire, England, www.bcs.org) The chartered body for information technology professionals in the U.K., founded in 1957. (R) XP System, the newest addition to the company's family of coagulation coagulation (kōăg'y  lā`shən), the collecting into a mass of minute particles of a solid dispersed throughout a liquid (a sol), usually followed by the precipitation or analyzers. Dade Behring is the world's largest company solely dedicated to clinical diagnostics and has a singular focus on serving the needs of the clinical laboratory. The BCS(R) XP System delivers customer-inspired features that resulted from interviews with current BCS(R) System customers. The BCS(R) System, launched in 1996, was the first of the family of analyzers and more than 1,500 instruments are being used in laboratories worldwide today. The features of the new BCS(R) XP System benefit today's high-volume coagulation laboratory. "The demands to improve productivity and efficiencies in the clinical laboratory increase everyday," said Jim Reid-Anderson, Chairman, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Dade Behring. "By listening to our customer's needs, we are able to provide them with innovation such as the BCS(R) XP System that not only improves their processes, but also helps them advance patient care in their facility." The BCS(R) XP System provides the most current technology in clotting, chromogenic chro·mo·gen·ic adj. Of or relating to a chromogen or to chromogenesis. chromogenic (krō´mōjen´ik), adj pertaining to color production. and immunologic methodologies. It has new innovative features, some of which are not found on any other coagulation analyzer today. Some of the features include: --Customizable software based on customer protocols to improve laboratory efficiency. --The latest science in coagulation testing--the automated Endogenous Thrombin thrombin: see blood clotting. Potential (ETP ETP Eligible Termination Payment (Australian finance) ETP Equivalent Temps Plein (French: Full Time Equivalent) ETP European Technology Platform ETP Employment Training Panel ) test, currently for Research Use Only. --An automated ristocetin cofactor cofactor An atom, organic molecule, or molecular group that is necessary for the catalytic activity (see catalysis) of many enzymes. A cofactor may be tightly bound to the protein portion of an enzyme and thus be an integral part of its functional structure, or it may activity test that detects Von Willebrand disease Von Willebrand Disease Definition Von Willebrand disease is caused by a deficiency or an abnormality in a protein called von Willebrand factor and is characterized by prolonged bleeding. , the most common inherited bleeding disorder. --Simultaneous specialty and routine testing to improve workflow in the laboratory. About Dade Behring Hemostasis (coagulation and platelet function testing) With more than 30 years of experience, Dade Behring is the largest provider of hemostasis analyzers in the world. Under its own name and through a global alliance with Sysmex Corporation, Dade Behring offers analyzer choices for the right fit in low-, medium-, and high-volume labs, including high-speed analyzers and cap piercing capability to improve operational efficiency in labs. The company is committed to the ongoing development of coagulation assays to assess bleeding and thrombotic risk. Dade Behring has many "firsts" in the coagulation industry including pioneering the first routine coagulation test using recombinant tissue factor--the Innovin(R) PT test. The company also developed the first automated ristocetin cofactor activity test that detects Von Willebrand disease, which is the most common inherited bleeding disorder. The company also has a leading position in automated platelet function analysis. About Dade Behring With 2005 revenue of nearly $1.7 billion, Dade Behring is the world's largest company solely dedicated to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of laboratories, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the Internet at www.dadebehring.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion